Relation of resistin to proprotein convertase subtilisin–kexin type 9 levels in coronary artery disease patients with different nutritional status
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Relation of resistin to proprotein convertase subtilisin–kexin type 9 levels in coronary artery disease patients with different nutritional status
Authors
Keywords
Proprotein convertase subtilisin/kexin type 9, Resistin, Coronary artery disease, Obesity
Journal
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
Volume 38, Issue 12, Pages 1291-1299
Publisher
Springer Nature
Online
2015-05-23
DOI
10.1007/s40618-015-0310-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association of plasma PCSK9 levels with white blood cell count and its subsets in patients with stable coronary artery disease
- (2014) Sha Li et al. ATHEROSCLEROSIS
- PCSK9 gene mutations and low-density lipoprotein cholesterol
- (2014) Na-Qiong Wu et al. CLINICA CHIMICA ACTA
- Hypertension and risk of immersion pulmonary edema
- (2014) Alain Boussuges et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Relation of Leukocytes and Its Subsets Counts with the Severity of Stable Coronary Artery Disease in Patients with Diabetic Mellitus
- (2014) Li-Feng Hong et al. PLoS One
- The Global Burden of Cardiovascular Diseases: A Challenge to Improve
- (2014) Shanthi Mendis et al. Current Cardiology Reports
- Interactions between inflammation and lipid metabolism: Relevance for efficacy of anti-inflammatory drugs in the treatment of atherosclerosis
- (2013) Janna A. van Diepen et al. ATHEROSCLEROSIS
- Insights Into PCSK9, Low-Density Lipoprotein Receptor, and Low-Density Lipoprotein Cholesterol Metabolism
- (2013) Evan A. Stein et al. CIRCULATION
- Short-Term Impact of Low-Dose Atorvastatin on Serum Proprotein Convertase Subtilisin/Kexin Type 9
- (2013) Yuan-Lin Guo et al. CLINICAL DRUG INVESTIGATION
- Targeting the Proprotein Convertase Subtilisin/Kexin Type 9 for the Treatment of Dyslipidemia and Atherosclerosis
- (2013) Daniel Urban et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Aging and Atherosclerosis
- (2012) Julie C. Wang et al. CIRCULATION RESEARCH
- Relationship of proprotein convertase subtilisin-kexin type 9 levels with resistin in lean and obese subjects
- (2012) Arjan J. Kwakernaak et al. CLINICAL BIOCHEMISTRY
- Discovery of a New Role of Human Resistin in Hepatocyte Low-Density Lipoprotein Receptor Suppression Mediated in Part by Proprotein Convertase Subtilisin/Kexin Type 9
- (2012) Michelle Melone et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Association of Adiponectin, Resistin, and Vascular Inflammation
- (2011) Hae Yoon Choi et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Clinical aspects of PCSK9
- (2011) Bertrand Cariou et al. ATHEROSCLEROSIS
- Resistin: functional roles and therapeutic considerations for cardiovascular disease
- (2011) Md S Jamaluddin et al. BRITISH JOURNAL OF PHARMACOLOGY
- Relation of resistin levels with cardiovascular risk factors, insulin resistance and inflammation in naïve diabetes obese patients
- (2010) D.A. de Luis et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Plasma PCSK9 Is Associated with Age, Sex, and Multiple Metabolic Markers in a Population-Based Sample of Children and Adolescents
- (2009) A. Baass et al. CLINICAL CHEMISTRY
- Chronic inflammatory status in patients with coronary artery ectasia
- (2009) Jian-Jun Li et al. CYTOKINE
- Molecular basis of PCSK9 function
- (2008) Gilles Lambert et al. ATHEROSCLEROSIS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now